Concepedia

Thomas J. Kandl

TJ

Statistics

Publications

6

Citations

364

H-Index

6

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thomas J. Kandl is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, tumor immunity, and tumor immunology.

Top concepts

Publications per year

2018–2018

6

Publications

6

Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma

Oded Sagiv, Sudip Thakar, Thomas J. Kandl et al. · JAMA Ophthalmology · 2018 · 110 citations · Full text

Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients

Ho-Seok Sa, Maria Laura Rubin, Shiqiong Xu et al. · British Journal of Ophthalmology · 2018 · 83 citations · Full text

Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients

Oded Sagiv, Thomas J. Kandl, Sudip Thakar et al. · Ophthalmic Plastic and Reconstructive Surgery · 2018 · 71 citations

Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma

Oded Sagiv, Priyadharsini Nagarajan, Renata Ferrarotto et al. · British Journal of Ophthalmology · 2018 · 51 citations

High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma

Thomas J. Kandl, Oded Sagiv, Jonathan L. Curry et al. · OncoImmunology · 2018 · 30 citations · Full text

, , +21

1–5 of 6